NO970894D0 - Farmasöytiske preparater inneholdende et gallesalt og en buffer for ökt biotilgjengelighet av en aktiv forbindelse - Google Patents
Farmasöytiske preparater inneholdende et gallesalt og en buffer for ökt biotilgjengelighet av en aktiv forbindelseInfo
- Publication number
- NO970894D0 NO970894D0 NO970894A NO970894A NO970894D0 NO 970894 D0 NO970894 D0 NO 970894D0 NO 970894 A NO970894 A NO 970894A NO 970894 A NO970894 A NO 970894A NO 970894 D0 NO970894 D0 NO 970894D0
- Authority
- NO
- Norway
- Prior art keywords
- buffer
- active compound
- pharmaceutical preparations
- preparations containing
- bile salt
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/28—Steroids, e.g. cholesterol, bile acids or glycyrrhetinic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/23—Calcitonins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/28—Insulins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/02—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P5/00—Drugs for disorders of the endocrine system
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB9417524A GB9417524D0 (en) | 1994-08-31 | 1994-08-31 | Pharmaceutical compositions |
PCT/GB1995/002015 WO1996006635A1 (en) | 1994-08-31 | 1995-08-25 | Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
Publications (2)
Publication Number | Publication Date |
---|---|
NO970894L NO970894L (no) | 1997-02-27 |
NO970894D0 true NO970894D0 (no) | 1997-02-27 |
Family
ID=10760623
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO970894A NO970894D0 (no) | 1994-08-31 | 1997-02-27 | Farmasöytiske preparater inneholdende et gallesalt og en buffer for ökt biotilgjengelighet av en aktiv forbindelse |
Country Status (13)
Country | Link |
---|---|
US (1) | US5853748A (de) |
EP (1) | EP0769960A1 (de) |
JP (1) | JPH10504835A (de) |
KR (1) | KR970705406A (de) |
AU (1) | AU705123B2 (de) |
CA (1) | CA2198721A1 (de) |
FI (1) | FI970825A0 (de) |
GB (1) | GB9417524D0 (de) |
IL (1) | IL115097A0 (de) |
NO (1) | NO970894D0 (de) |
NZ (1) | NZ291863A (de) |
WO (1) | WO1996006635A1 (de) |
ZA (1) | ZA957247B (de) |
Families Citing this family (61)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE295176T1 (de) | 1997-05-19 | 2005-05-15 | Repligen Corp | Verfahren zur unterstützung der differentialdiagnostik und behandlung von autistischen syndromen |
US6197746B1 (en) | 1998-05-19 | 2001-03-06 | Repligen Corporation | Method of using secretin for treating autism |
EP1012331B1 (de) | 1997-07-01 | 2006-03-29 | Isis Pharmaceuticals, Inc. | Zusammensetzungen und verfahren zur verabreichung von oligonukleotiden über die speiseröhre |
US7070799B1 (en) * | 1998-02-10 | 2006-07-04 | Generex Pharmaceuticals, Inc. | Method for administering insulin to the buccal region |
US6221378B1 (en) | 1998-02-10 | 2001-04-24 | Generex Pharmaceuticals Incorporated | Mixed micellar delivery system and method of preparation |
US20030118645A1 (en) * | 1998-04-29 | 2003-06-26 | Pather S. Indiran | Pharmaceutical compositions for rectal and vaginal administration |
US6974590B2 (en) * | 1998-03-27 | 2005-12-13 | Cima Labs Inc. | Sublingual buccal effervescent |
US20030091629A1 (en) | 1998-03-27 | 2003-05-15 | Cima Labs Inc. | Sublingual buccal effervescent |
EP1080103A4 (de) * | 1998-05-21 | 2003-07-02 | Isis Pharmaceuticals Inc | Zubereitungen und verfahren zur nicht-parenteralen verabreichung von oligonukleotiden |
WO1999065493A1 (en) * | 1998-06-18 | 1999-12-23 | The George Washington University | Methods of administering camptothecin compounds for the treatment of cancer with reduced side effects |
TW570805B (en) * | 1998-09-01 | 2004-01-11 | Hoffmann La Roche | Water-soluble pharmaceutical composition in an ionic complex |
US6294153B1 (en) | 1998-12-21 | 2001-09-25 | Generex Pharmaceuticals, Inc. | Aerosol pharmaceutical formulation for pulmonary and nasal delivery |
US6761903B2 (en) | 1999-06-30 | 2004-07-13 | Lipocine, Inc. | Clear oil-containing pharmaceutical compositions containing a therapeutic agent |
US6350432B1 (en) | 1999-03-19 | 2002-02-26 | Generex Pharmaceuticals Incorporated | Pressurized container having an aerosolized pharmaceutical composition |
US6458383B2 (en) | 1999-08-17 | 2002-10-01 | Lipocine, Inc. | Pharmaceutical dosage form for oral administration of hydrophilic drugs, particularly low molecular weight heparin |
GB2355009A (en) | 1999-07-30 | 2001-04-11 | Univ Glasgow | Peptides conjugated to bile acids/salts |
US9357797B2 (en) | 1999-11-06 | 2016-06-07 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
US20030235629A1 (en) * | 1999-11-06 | 2003-12-25 | Janmarie Hornack | Dietary supplement containing alkaline electrolyte buffers |
US20030003537A1 (en) * | 2001-04-30 | 2003-01-02 | Ventana Medical Systems, Inc. | Method and composition of matter for enhancing staining of microorganisms |
US6828305B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of growth hormone drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6828297B2 (en) | 2001-06-04 | 2004-12-07 | Nobex Corporation | Mixtures of insulin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US6858580B2 (en) * | 2001-06-04 | 2005-02-22 | Nobex Corporation | Mixtures of drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US7713932B2 (en) | 2001-06-04 | 2010-05-11 | Biocon Limited | Calcitonin drug-oligomer conjugates, and uses thereof |
US6713452B2 (en) * | 2001-06-04 | 2004-03-30 | Nobex Corporation | Mixtures of calcitonin drug-oligomer conjugates comprising polyalkylene glycol, uses thereof, and methods of making same |
US20030068356A1 (en) * | 2001-07-10 | 2003-04-10 | Pather S. Indiran | Sequential drug delivery systems |
US6770625B2 (en) | 2001-09-07 | 2004-08-03 | Nobex Corporation | Pharmaceutical compositions of calcitonin drug-oligomer conjugates and methods of treating diseases therewith |
US6913903B2 (en) | 2001-09-07 | 2005-07-05 | Nobex Corporation | Methods of synthesizing insulin polypeptide-oligomer conjugates, and proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US7312192B2 (en) | 2001-09-07 | 2007-12-25 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
US7030082B2 (en) * | 2001-09-07 | 2006-04-18 | Nobex Corporation | Pharmaceutical compositions of drug-oligomer conjugates and methods of treating disease therewith |
US7166571B2 (en) | 2001-09-07 | 2007-01-23 | Biocon Limited | Insulin polypeptide-oligomer conjugates, proinsulin polypeptide-oligomer conjugates and methods of synthesizing same |
JP5462429B2 (ja) | 2002-01-16 | 2014-04-02 | アステラス製薬株式会社 | 経口吸収改善用医薬組成物 |
GB0217056D0 (en) * | 2002-07-23 | 2002-08-28 | Ass Octel | Use |
GB0308734D0 (en) * | 2003-04-15 | 2003-05-21 | Axcess Ltd | Uptake of macromolecules |
GB0308732D0 (en) * | 2003-04-15 | 2003-05-21 | Axcess Ltd | Absorption enhancers |
ATE500821T1 (de) | 2003-12-31 | 2011-03-15 | Cima Labs Inc | Brauseformen von opiaten zur oralen anwendung und verfahren zur verabreichung von oxycodon |
US7858121B2 (en) * | 2003-12-31 | 2010-12-28 | Cima Labs, Inc. | Effervescent oral fentanyl dosage form and methods of administering fentanyl |
BRPI0418228B8 (pt) * | 2003-12-31 | 2021-05-25 | Cima Labs Inc | forma de dosagem, e, método de preparação de um tablete para administração bucal, gengival ou sublingual de fentanil |
CA2563533C (en) * | 2004-04-15 | 2013-10-01 | Shmuel A. Ben-Sasson | Compositions capable of facilitating penetration across a biological barrier |
US20070219131A1 (en) * | 2004-04-15 | 2007-09-20 | Ben-Sasson Shmuel A | Compositions capable of facilitating penetration across a biological barrier |
MX2007000883A (es) | 2004-07-19 | 2007-04-02 | Biocon Ltd | Conjugados de insulina-oligomero, formulaciones y usos de los mismos. |
MX2008004674A (es) * | 2005-10-13 | 2008-11-12 | Biocon Ltd | Proceso para la preparacion de conjugados de insulina. |
KR100700948B1 (ko) * | 2006-05-25 | 2007-03-28 | 삼성전자주식회사 | 이동통신 시스템에서 무선 랜의 다중 채널을 이용하는데이터 전송 장치 및 방법 |
EP2203181B1 (de) | 2007-10-16 | 2018-02-14 | Biocon Limited | Oral zu verabreichende feste pharmazeutische zusammensetzung und verfahren dafür |
FR2925333B1 (fr) * | 2007-12-19 | 2012-04-13 | Farid Bennis | Compositions pharmaceutiques renfermant au moins un principe actif proteinique protege des enzymes digestives |
US20100105627A1 (en) | 2008-09-17 | 2010-04-29 | Paul Salama | Pharmaceutical compositions and related methods of delivery |
GB0817969D0 (en) * | 2008-10-01 | 2008-11-05 | Axcess Ltd | Pharmaceutical composition |
US11304960B2 (en) | 2009-01-08 | 2022-04-19 | Chandrashekar Giliyar | Steroidal compositions |
US8101593B2 (en) | 2009-03-03 | 2012-01-24 | Kythera Biopharmaceuticals, Inc. | Formulations of deoxycholic acid and salts thereof |
US20180153904A1 (en) | 2010-11-30 | 2018-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9358241B2 (en) | 2010-11-30 | 2016-06-07 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US9034858B2 (en) | 2010-11-30 | 2015-05-19 | Lipocine Inc. | High-strength testosterone undecanoate compositions |
US20120148675A1 (en) | 2010-12-10 | 2012-06-14 | Basawaraj Chickmath | Testosterone undecanoate compositions |
EP2675460A4 (de) | 2011-02-18 | 2014-07-09 | Kythera Biopharmaceuticals Inc | Behandlung von fettgewebe unter dem kinn |
NZ727407A (en) | 2014-06-27 | 2018-12-21 | Medytox Inc | Methods and compositions of bile acids and salts for reduction of fat |
US20170246187A1 (en) | 2014-08-28 | 2017-08-31 | Lipocine Inc. | (17-ß)-3-OXOANDROST-4-EN-17-YL TRIDECANOATE COMPOSITIONS AND METHODS OF THEIR PREPARATION AND USE |
WO2016033556A1 (en) | 2014-08-28 | 2016-03-03 | Lipocine Inc. | BIOAVAILABLE SOLID STATE (17-β)-HYDROXY-4-ANDROSTEN-3-ONE ESTERS |
US10238709B2 (en) | 2015-02-03 | 2019-03-26 | Chiasma, Inc. | Method of treating diseases |
CA3078723A1 (en) | 2016-11-28 | 2018-05-31 | Nachiappan Chidambaram | Oral testosterone undecanoate therapy |
US11141457B1 (en) | 2020-12-28 | 2021-10-12 | Amryt Endo, Inc. | Oral octreotide therapy and contraceptive methods |
GB2625490A (en) * | 2021-01-27 | 2024-06-19 | D&D Pharmatech Inc | Pharmaceutical composition comprising large physiologically active substance and excipient |
AU2022344774A1 (en) * | 2021-09-07 | 2024-03-14 | D&D Pharmatech Inc. | Pharmaceutical composition comprising large physiologically active substance and excipient |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL68769A (en) * | 1983-05-23 | 1986-02-28 | Hadassah Med Org | Pharmaceutical compositions containing insulin for oral administration |
GB8909022D0 (en) * | 1989-04-20 | 1989-06-07 | Cortecs Ltd | Pharmaceutical compositions |
GB9013448D0 (en) * | 1990-06-15 | 1990-08-08 | Sandoz Ltd | Pharmaceutical resorption-improved somatostatin compositions,their preparation and use |
JPH04149126A (ja) * | 1990-10-09 | 1992-05-22 | Mitsubishi Kasei Corp | 経粘膜投与用医薬組成物 |
IT1245890B (it) * | 1991-04-12 | 1994-10-25 | Alfa Wassermann Spa | Formulazioni farmaceutiche per uso orale gastroresistenti contenenti acidi biliari. |
DE4234537A1 (de) * | 1992-10-14 | 1994-04-21 | Hoechst Ag | Zubereitung, enthaltend Insulin und polymere Gallensäure |
-
1994
- 1994-08-31 GB GB9417524A patent/GB9417524D0/en active Pending
-
1995
- 1995-08-25 CA CA002198721A patent/CA2198721A1/en not_active Abandoned
- 1995-08-25 NZ NZ291863A patent/NZ291863A/xx unknown
- 1995-08-25 EP EP95929955A patent/EP0769960A1/de not_active Withdrawn
- 1995-08-25 AU AU33510/95A patent/AU705123B2/en not_active Ceased
- 1995-08-25 KR KR1019970701088A patent/KR970705406A/ko not_active Application Discontinuation
- 1995-08-25 WO PCT/GB1995/002015 patent/WO1996006635A1/en not_active Application Discontinuation
- 1995-08-25 JP JP8508551A patent/JPH10504835A/ja active Pending
- 1995-08-29 ZA ZA957247A patent/ZA957247B/xx unknown
- 1995-08-29 IL IL11509795A patent/IL115097A0/xx unknown
-
1997
- 1997-02-24 US US08/804,508 patent/US5853748A/en not_active Expired - Lifetime
- 1997-02-27 FI FI970825A patent/FI970825A0/fi unknown
- 1997-02-27 NO NO970894A patent/NO970894D0/no unknown
Also Published As
Publication number | Publication date |
---|---|
CA2198721A1 (en) | 1996-03-07 |
NO970894L (no) | 1997-02-27 |
AU705123B2 (en) | 1999-05-13 |
KR970705406A (ko) | 1997-10-09 |
ZA957247B (en) | 1997-02-28 |
MX9701455A (es) | 1998-05-31 |
IL115097A0 (en) | 1996-01-19 |
FI970825A (fi) | 1997-02-27 |
AU3351095A (en) | 1996-03-22 |
FI970825A0 (fi) | 1997-02-27 |
GB9417524D0 (en) | 1994-10-19 |
EP0769960A1 (de) | 1997-05-02 |
WO1996006635A1 (en) | 1996-03-07 |
US5853748A (en) | 1998-12-29 |
JPH10504835A (ja) | 1998-05-12 |
NZ291863A (en) | 1998-12-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO970894D0 (no) | Farmasöytiske preparater inneholdende et gallesalt og en buffer for ökt biotilgjengelighet av en aktiv forbindelse | |
IL117728A (en) | Pharmaceutical compositions for transdermal administration comprising an active principle a promotor and a solvent | |
IS4644A (is) | Setin bensýlamínópíperidín efnasambönd og lyfjablöndur þeirra | |
NO954146D0 (no) | Belagte farmasöytiske preparater | |
NO933647L (no) | Karboksylsyrederivater, legemidler inneholdende disse og fremgangsmåte for deres fremstilling | |
NO941358D0 (no) | Vandig farmasöytisk suspensjon og fremgangsmåte for fremstilling derav | |
ATE226819T1 (de) | Arzneizubereitungen für piperidinalkanolderivate | |
NO940913D0 (no) | Preparater for kontrollert frigivelse av biologisk aktiv TGF- | |
NO961136D0 (no) | Farmasöytisk formuleringsgrunnlag for nano-suspensjoner | |
EE03280B1 (et) | Pidurdatud vabanemisega ravimkuulikesed ja neid sisaldav ravimpreparaat | |
KR970006279A (ko) | 약제학적 활성 성분으로서의 6-디메틸아미노메틸-1-페닐-사이클로헥산 화합물 | |
NO965376D0 (no) | Farmasötiske preparater og metoder for formulering av signaltransduksjon | |
FI962948A (fi) | Menetelmä vaikealiukoisten farmaseuttisesti aktiivisten aineiden liuottamiseksi | |
NO961294D0 (no) | Anordning for aktiv bestanddel | |
KR970000228A (ko) | S-에토돌락의 경구용 제제 | |
NO981241D0 (no) | Heteroarylsubstituerte akryloylguanidinderivater og farmasöytiske preparater inneholdende disse | |
ITMI921413A0 (it) | Preparazioni farmaceutiche stabili di nicorandil | |
DK287188D0 (da) | Cephalosporinforbindelser og farmaceutisk praeparat deraf | |
NO20006576L (no) | Et substituert triazol-pyridazinderivat og farmasöytiske preparater fremstilt av dette | |
NO304890B1 (no) | Farmas°ytiske forbindelser og farmas°ytiske preparater | |
NO943834L (no) | Fremgangsmåte ved innkapsling av en aktiv bestanddel | |
PL327580A1 (en) | Derivatives of thioles exhibiting metallopepsidase inhibiting activity | |
AU2229392A (en) | Method for the preparation of prolonged-release oral pharmaceutical forms containing active substances having a solubility dependent upon the ph value | |
NO302398B1 (no) | Vandige farmasöytiske preparater av natriumkromoglykat og farmasöytisk forpakning | |
AU3471995A (en) | Pharmaceutical formulations comprising clavulanic acid or derivatives and an organic acid or salt |